Andy Tran is a California-based investor with a background in bioengineering. He attended Harvard University where he studies Bioengineering and Computer Science. Andy is a partner on the bio investment team, where he focuses on companies at the intersection of biology, engineering, and healthcare.He worked as a bioengineer before becoming involved with investing and in 2018, he became a partner at Andreessen Horowitz, focusing on investing in healthcare and biotechnology companies.
Prior to joining a16z, Andy worked in Genentech’s Discovery Oncology department, where he developed high-throughput, genome-wide screens and computational tools for identifying novel cancer targets. Before that, Andy worked with Professor George Church at the Harvard Medical School/Wyss Institute, where he engineered CRISPR genome editing technologies for therapeutic applications. Andy also analyzed high-growth technology companies in the investment banking division of Morgan Stanley.
mputers, and swimming.
While not searching for the next frontier in bio, Andy enjoys playing the guitar, building computers, and swimming.
16 Open Problems in Engineering Biology - Andreessen Horowitz
Vijay Pande and Andy Tran
July 22, 2020